Hepatitis B virus

• 

  Subject Areas on Research

  • A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. 
  • A rationalized approach to the treatment of patients infected with hepatitis B. 
  • Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. 
  • Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. 
  • Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. 
  • Association of aflatoxin B1 levels with mean CD4 cell count and uptake of ART among HIV infected patients: A prospective study. 
  • Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients. 
  • Autoimmune hepatitis in a child with chronic hepatitis B virus infection. 
  • Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. 
  • Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. 
  • Clinical relevance of hepatitis B viral mutations. 
  • Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. 
  • Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection. 
  • Development of fatal acute liver failure in HIV-HBV coinfected patients. 
  • Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response? 
  • Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee. 
  • Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. 
  • Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. 
  • HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study. 
  • HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. 
  • Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study. 
  • Hepatitis B and C viruses in infants and young children. 
  • Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation. 
  • Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience. 
  • Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. 
  • Hepatitis B surface antigen could harbour the infective agent of AIDS. 
  • Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management. 
  • Hepatitis B virus antibody status provides new insights in diffuse large B-Cell lymphoma. 
  • Hepatitis B virus vaccine. An analysis of its potential use in medical workers. 
  • Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. 
  • Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels. 
  • Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques. 
  • Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure. 
  • Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma. 
  • Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. 
  • Kaposi's sarcoma and hepatitis B vaccine. 
  • Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. 
  • Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV). 
  • Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin. 
  • Maternal immunisation and neonatal infection of hepatitis A or B virus - Authors' reply. 
  • N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle. 
  • Non-Hodgkin's lymphomas, version 1.2013. 
  • Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression. 
  • Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation. 
  • Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. 
  • Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. 
  • Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. 
  • Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection. 
  • Reprogramming of cellular metabolic pathways by human oncogenic viruses. 
  • Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. 
  • Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B. 
  • SENP3-mediated host defense response contains HBV replication and restores protein synthesis. 
  • Stemming the tide of hepatitis B virus related hepatocellular carcinoma? 
  • TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. 
  • The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection. 
  • Therapy of acute and fulminant hepatitis B. 
  • Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load. 
  • Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. 
  • Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. 
  • Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.